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Letter to the Editor
Autophagy in Renal Ischemia-Reperfusion Injury:
Friend or Foe?
To the Editor:
The recent review on autophagy by Pallet et al published
in the Journal addresses the interesting possibility to
promote autophagy to limit ischemia-reperfusion injury
(IRI) and reduce delayed graft function after kidney
transplantation (1). Indeed, autophagy is generally regarded
as a protective response to various types of pathological
injuries—among them renal IRI—and its stimulation may
therefore improve graft outcome.
Pallet et al (1) judiciously notice that certain well-known
stimulators of autophagy, such as rapamycin (mTOR
inhibitor), paradoxically aggravate IRI. They attribute this
discrepancy to the fact that mTOR inhibitors not only
stimulate autophagy but also inhibit cell growth, essential
for kidney recovery after injury. For this reason, Pallet et
al (1) propose to evaluate a more selective autophagy
stimulator: the cell-permeable peptide Tat-Beclin 1.
With this letter we want to highlight that stimulation of
autophagy may not necessarily protect the graft. Indeed,
Liu et al (2) recently demonstrated the existence of
autophagy-dependent cell death in various cell lines and a
pathological model of cerebral ischemia. This process,
termed ‘‘autosis,’’ is triggered by high levels of autophagy
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(a) Liu  S Autophagy 2012: 8(5) 25 min (f) Nakagawa S Eur J Pharmacol 2012: 696(1-3) 40 min 
(b) Jiang M Kidney Int 2012:  82(12) 25 min (g) Chien CT Transplantaon 2007: 84(9) 45 min 
(c) Jiang M Am J Pathol 2010: 176(3) 30 min (h) Isaka Y Transplant Proc 2009: 41(1) 45 min 
(d) Kimura T J Am Soc Nephrol 2011: 22(5) 40 min (i) Yeh CH Life Sci 2010: 86(3-4) 45 min 
(e) Lempiainen J Acta Physiol 2013: 208(4)  40 min (j) Wu HH J Biomed Sci 2009: 16(1) 60 min 
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Figure 1: Proposed model. The longer the ischemic time (the ischemic severity), the greater the chance of excessive detrimental
autophagy or autosis, as suggested by analysis of the different publications, summarized in the table below the scheme. Protective
autophagy was found in models with 25–40min of ischemia (a–e), detrimental autophagy was observed upon 40–60min of ischemia (f–j).
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(2) and was induced by the autophagy stimulator Tat-Beclin
1 that Pallet et al (1) are considering to evaluate in the
protection of kidney grafts from IRI.
We hypothesize that autophagy may have both protective
and detrimental effects depending on the severity of
ischemia, the degree of autophagy activation, the phase of
IRI and probably other still unknown factors. This concept of
a dual effect of autophagy is supported by the findings of all
the reports on in vivo autophagy modulation in renal IRI;
autophagy was protective when ischemia time was short
(20–40min), but detrimental aftermore prolonged ischemia
(40–60min) (Figure 1). More severe ischemia could
increase the likelihood of high levels of autophagy leading
to cell death, as described by Liu et al (2). Ischemia of 40min
likely represents the ‘‘fatal’’ turning point above which
autophagy transforms from a cell survival into a cell death
pathway in the examined models, but the turning point will
likely vary according to the species, strain, gender and the
type (warm or cold) and length of ischemia in the studied
model.
Consequently, it is essential to unravel the characteristics
of autophagy in renal IRI and the factors influencing them.
Beyond that, other transplant-related injuries (hypoxia and
surgical manipulation in donors and recipients, cold
preservation, drug toxicity, etc.) likely also affect autophagy
as it is a ubiquitous cell adaptation process. Finally,
autophagy likely also plays a role in graft rejection since it
regulates innate and adaptive immune cells. We agree with
Pallet et al (1) that modulating autophagy represents a new
avenue to protect kidney grafts from IRI that needs to be
explored. However, the complexity and themultitude of the
transplant-related events influencing autophagy, the proba-
bly ambivalent (protective and detrimental) characteristics
of autophagy and the involvement of multiple cell compart-
ments (parenchymal and nonparenchymal) may make this
strategy very challenging.
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